about
High levels of subgenomic HCV plasma RNA in immunosilent infectionsIntroduction of lamivudine for the treatment of chronic hepatitis B: expected clinical and economic outcomes based on 4-year clinical trial data.Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriersDeterminants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance.An intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers.Precore and core promoter mutations of the hepatitis B virus gene in chronic genotype C-infected children.Natural history of hepatitis B in perinatally infected carriers.Chinese medicines as a resource for liver fibrosis treatmentDistribution and epidemiologic trends of HBV genotypes and subtypes in 14 countries neighboring chinaEffect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control studyIntroduction to chronic hepatitis B infection.Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection.Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver.Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion.Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional studyRevisiting the natural history of chronic hepatitis B: impact of new concepts on clinical management.Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.Detection of intrahepatic hepatitis B virus DNA and correlation with hepatic necroinflammation and fibrosis.Treatment of viral hepatitis B in children.Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy.Relationship between hepatitis B DNA viral load in the liver and its histology in patients with chronic hepatitis B.Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.B alert: hepatitis B virus infection in children in Victoria.JGH and Asia-Pacific consensus on prevention and management of gastrointestinal and liver diseases.In situ expression of Granzyme B and Fas-ligand in the liver of viral hepatitis.Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection.The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B.Chronic hepatitis B: a long-term retrospective cohort study of disease progression in Shanghai, China.Cholangiocarcinoma in liver cirrhosis.
P2860
Q27481224-1B332EFF-26AF-4EA1-BAFB-D18747397F86Q30689186-5A5251D1-F44D-46CC-9A5B-2AAB95500B07Q33749894-09B246CB-5504-4A0C-A0BD-BFBEB96477C7Q33753308-71812B0A-09AC-4F2A-8EB2-2BFF3AD362EBQ33968189-72D30F76-2ACF-4045-80E6-385A6C873417Q34753430-477C735B-5339-4948-B607-4B8B6AAD7766Q35295393-01DB0D1F-E51A-45DF-A638-13C77E8977EEQ35575460-B2EA4E5F-3971-47CE-A01E-188B8B2C68E5Q35671668-CB499149-78D7-47BB-9016-1EB9CDBA9942Q35832967-AB854A48-C61B-4DF8-AB99-458F0C53F6D2Q36382631-7B762DA4-448E-41DE-B856-AE80179537A7Q36496627-AECDC518-B0FC-4431-A08E-0A1E944EFBF6Q36577653-07CBA8CB-0F2D-4D6D-B429-D2236B519993Q36738157-85D20D28-0FAF-4A46-BA7B-3B8499C7D599Q36767379-1C7E88DA-9EFB-4256-911A-6C87F18A90AAQ36816153-4FD51F8E-DBE2-4F57-B69B-1524F53C9B4EQ37444284-F726CC93-D49C-4B7A-86A0-763DA6D55B28Q37511323-203C6EB4-578B-457D-8741-90C5A4AFA82FQ37702241-E48FCC98-FB5C-458F-A617-8096B894E2E7Q38027061-0C6FB76F-4C91-4337-B7E9-17500C838E23Q38908489-1921F851-C410-48D2-BCD2-B99A86AE3835Q40197931-45287ACD-8437-4BE9-84E4-3E768D34F534Q42271635-C038A5AB-5B5E-4B5A-90E1-8B0EABB2A900Q43879413-7C741000-6323-424F-B2B5-64CAAAE3BAB7Q44052116-5A128EFE-0946-4325-8907-19306713F697Q45163314-F5ECC09E-9E8D-4335-9E98-B3E6E37E2981Q46572233-BA8C4A58-14E9-453C-B1AC-402C6EEE30E0Q47320418-F387F0DA-EF14-4F37-AC24-010193B8308EQ53658023-D54700E7-39D2-4808-AC85-04AB2590FB72
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Natural history of chronic hepatitis B virus infection.
@en
Natural history of chronic hepatitis B virus infection.
@nl
type
label
Natural history of chronic hepatitis B virus infection.
@en
Natural history of chronic hepatitis B virus infection.
@nl
prefLabel
Natural history of chronic hepatitis B virus infection.
@en
Natural history of chronic hepatitis B virus infection.
@nl
P2860
P1476
Natural history of chronic hepatitis B virus infection.
@en
P2860
P356
10.1046/J.1440-1746.2000.02123.X
P478
P577
2000-05-01T00:00:00Z